Abstract
Background: This is a narrative review of both the literature and Internet pertaining to telemedicine projects within the field of heart failure, with special attention placed on remote monitoring of second-generation projects and trials, particularly in France. Results: Since the beginning of the 2000’s, several telemedicine projects and trials focused on chronic heart failure have been developed. The first telemedicine projects (e.g., TEN-HMS, BEAT-HF, Tele-HF, and TIM-HF) primarily investigated telemonitoring or for the older ones, telephone follow-up. Numerous second-generation telemedicine projects have emerged in Europe over the last ten years or are still under development for computer science heart failure, especially in Europe, such as SCAD, OSICAT, E-care, PRADO-INCADO, and TIM-HF2. The E-care telemonitoring project fits within the telemedicine 2.0 framework, based on connected objects, new information and communication technologies (ICT) and Web 2.0 technologies. E-care is the first telemedicine project including artificial intelligence (AI). TIM-HF2 is the first positive prospective randomized study with regards to EBM with positive significant clinical benefit, in terms of unplanned cardiovascular hospital admissions and all-cause deaths. The potential contribution of second-generation telemedicine projects in terms of mortality, morbidity, and number of hospitalizations avoided is currently under study. Their impact in terms of health economics is likewise being investigated, taking into account that the economic and social benefits brought up by telemedicine solutions were previously validated by the original telemedicine projects.
Highlights
The rising prevalence of chronic diseases, e.g., chronic heart failure (CHF) or diabetes mellitus (DM), represents a real concern for public health [1]
The percentage of days lost due to unplanned cardiovascular hospital admissions and all-cause deaths was 4.88% in the remote patient management group vs
The percentage of days lost due to unplanned cardiovascular hospital admissions and all-cause deaths was 4.88% in the remote patient management group v6s..646%.64(%6.1(96–.71.91–37).1in3)thine stthaendsatardndcaarrde gcraoruepg(rroautipo (0r.a8t0i,o950%.80C, I9:50%.65C–1I:; p0.=650–.10;46p0)=
Summary
The rising prevalence of chronic diseases, e.g., chronic heart failure (CHF) or diabetes mellitus (DM), represents a real concern for public health [1]. Approximately 150,000 new heart failure (HF) cases are diagnosed every year The cost of this chronic disease, which has recently skyrocketed, is estimated at several billion dollars in developed countries [1]. Despite major therapeutic advances, most chronic diseases remain serious in terms of functional or survival prognosis, with high morbidity and mortality rates [3] This applies to CHF, with a five-year mortality rate based on the New York Heart Association (NYHA) at classes III-IV and is estimated to be between 20% and 40%, and approach that of metastatic breast cancer [2,3]. We have reported on the experience gained with current telemonitoring projects in France
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
